Original Research Article

Ultrasound Characteristics of Thyroid Nodules: Differentiating Benign from Malignant Nodules Using Histopathology as the Gold Standard.

1 Department of Radiology, King Fahad General Hospital, Ministry of Health, Al-Madinah, Saudi Arabia

Published: 11 May 2026

Abstract
Background: Thyroid nodules are a common clinical finding. Accurate differentiation between benign and malignant nodules is crucial for determining appropriate management and treatment. Ultrasound is the primary imaging modality for evaluating thyroid nodules, providing valuable information on characteristics such as echogenicity, size, and vascularity. Despite its widespread use, the diagnostic accuracy of ultrasound in distinguishing benign from malignant nodules varies, necessitating further research to establish reliable ultrasound markers. Therefore, this study aimed to evaluate ultrasound characteristics of thyroid nodules to differentiate benign from malignant nodules using histopathology as the gold standard. Materials and Methods: This retrospective study analyzed 175 thyroid nodules from 155 patients who underwent thyroid ultrasound and subsequent fine-needle aspiration (FNA) or core-needle biopsy (CNB) at King Fahad Hospital, Saudi Arabia, between 2021 and 2024. Ultrasound features, including echogenicity, size, and vascularity, were recorded and analyzed. The Chi-square test was used for categorical variables, and the Mann-Whitney U test was employed for nodule size measurements. Results: Out of 175 nodules, 154 were benign and 21 were malignant. A significant association was found between gender and nodule diagnosis (p=0.05), with overall and malignant thyroid nodules more frequently observed in females than in males. Malignant nodules were more likely to be hypoechoic when compared to surrounding normal thyroid tissue than benign nodules (p=0.002). No significant differences were observed in hyperechoic, isoechoic, mixed echogenicity, or vascularity patterns, nor in nodule size dimensions between benign and malignant thyroid nodules. Conclusion: This study highlights the importance of thyroid nodules echogenicity as a predictor of malignancy in thyroid nodules, while other ultrasound features, such as size and vascularity, did not significantly correlate with malignancy. Further prospective, multi-center research is needed to validate these findings and improve diagnostic accuracy in thyroid nodule management.
KeywordsThyroid nodules, Ultrasound, Histopathology,

License

Journal License

This work is licensed under a Creative Commons Attribution 4.0 International license

References

  1. [1] Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to non-
  2. palpable nodules discovered incidentally on thyroid imaging. Ann Intern Med.
  3. 1997;126(3):226–257.
  4. [2] [3] Angell TE, Maurer R, Wang Z, Kim MI, Alexander CA, Barletta JA. A Cohort Analysis
  5. of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive
  6. Thyroid Nodules. J Clin Endocrinol Metab. 2019;104(11):5665–72.
  7. Wang C, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL. A large mul-
  8. ticenter correlation study of thyroid nodule cytopathology and histopathology. Thy-
  9. roid. 2011;21(3):243–51.
  10. [4] Alexander EK, Cibas ES. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol.
  11. 2022;10(7):533–542. [5] Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE. Amer-
  12. ican Thyroid Association Management Guidelines for Adult Patients with Thyroid
  13. Nodules and Differentiated Thyroid Cancer: The American Thyroid Association
  14. Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thy-
  15. roid. 2015;26(1):1–133.
  16. [6] Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics. 2010;60(5):277–300.
  17. [7] Ma X, Zhang L. Diagnosis of Thyroid Nodules Based on Image Enhancement and
  18. Deep Neural Networks. Comput Intell Neurosci. 2022;.
  19. [8] Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA. ACR Thy-
  20. roid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-
  21. RADS Committee. Journal of the American College of Radiology. 2017;14(5):587–
  22. 95.
  23. [9] Bahaj AS, Alkaff HH, Melebari BN, Melebari AN, Sayed SI, Mujtaba SS. of fine-needle aspiration cytology in evaluating thyroid nodules. 2020;41(10):1098–103.
  24. Role
  25. Saudi Med J.
  26. [10] Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA. ACR Thy-
  27. roid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-
  28. RADS Committee. Journal of the American College of Radiology. 2017;14(5):587–
  29. 95.
  30. [11] Harris RD, Langer JE, Levine RA, Sheth S, Abramson SJ, Gabriel H. AIUM Practice
  31. Guideline for the Performance of a Thyroid and Parathyroid Ultrasound Examina-
  32. tion. Journal of Ultrasound in Medicine. 2013;32(7):1319–1348.
  33. [12] Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L et al. Thy-
  34. roid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid
  35. Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017;6(5):225–262.
  36. [13] Morgan JL, Serpell JW, Cheng M. Fine-needle aspiration cytology of thyroid nodules:
  37. how useful is it? ANZ J Surg. 2003;73(7):480–483.
  38. [14] Jogai S, Al-Jassar A, Temmim L, Dey P, Adesina AO, Amanguno HG. Fine needle
  39. aspiration cytology of the thyroid: a cytohistologic study with evaluation of discor-
  40. dant cases. Acta Cytol. 2005;49(5):483–491.
  41. [15] Kamal MM, Arjune DG, Kulkarni HR. Comparative study of fine needle aspiration
  42. and fine needle capillary sampling of thyroid lesions. Acta Cytol. 2002;46(1):30–34. [16] Bukhari MH, Niazi S, Hanif G, Qureshi SS, Munir M, Hasan M. An updated
  43. audit of fine needle aspiration cytology procedure of solitary thyroid nodule. Diagn
  44. Cytopathol. 2008;36(2):104–116.
  45. [17] Moon HJ, Sung JM, Kim EK, Yoon JH, Youk JH, Kwak JY. mance of Gray-Scale US and Elastography in Solid Thyroid Nodules. 2012;262(3):1002–1015.
  46. Diagnostic Perfor-
  47. Radiology.
  48. [18] Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis
  49. and Management of Thyroid Nodules: A Review. JAMA. 2018;319(9):914–938.
  50. [19] Moon WJ, So LJ, Jeong HL, Dong GN, Baek JH, Young HL. Benign and Malignant
  51. Thyroid Nodules: US Differentiation-Multicenter Retrospective Study. Radiology.
  52. 2008;247(3):762–70.
  53. [20] Alamdaran SA, Farshidianfar M, Masoumi A, Rashed MM, Jaberi M. Diagnostic
  54. value of colour Doppler ultrasound in differentiating malignant and benign nodules
  55. in thyroiditis background. J Med Radiat Sci. 2024;71(2):233–233.
  56. [21] Zhao D, Jing Y, Lin X, Zhang B. The value of color Doppler ultrasound in the diag-
  57. nosis of thyroid nodules: a systematic review and meta-analysis. Gland Surgery.
  58. 2021;10(12):3369–3377.
  59. [22] Salehi M, Nalaini F, Izadi B, Setayeshi K, Rezaei M, Naseri SN et al. Gray-scale vs.
  60. color doppler ultrasound in cold thyroid nodules. Glob J Health Sci. 2014;7(3):147–
  61. 52.
  62. [23] Bakhshaee M, Davoudi Y, Mehrabi M, Layegh P, Mirsadaee S, Rad MP et al. Vas-
  63. cular Pattern and Spectral Parameters of Power Doppler Ultrasound as Predictors of
  64. Malignancy Risk in Thyroid Nodules. The Laryngoscope. 2008;118(12):2182–2186.
  65. [24] A MHK, and Hagag Ali A AESZ. ROLE OF ULTRASONOGRAPHY AND COLOR
  66. DOPPLER IMAGING IN IDENTIFICATION OF THYROID NODULES SUSPI-
  67. CIOUS OF MALIGNANCY FOR FINE NEEDLE ASPIRATION. Ain Shams Med
  68. J. 2021;p. 72.
  69. [25] Kalantari S. The Diagnostic Value of Color Doppler Ultrasonography in Predicting
  70. Thyroid Nodules Malignancy. The International Tinnitus Journal. 2018;22(1):35–44.
  71. [26] Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H et al. Thyroid Nod-
  72. ule Size and Prediction of Cancer. The Journal of Clinical Endocrinology &
  73. Metabolism. 2013;98(2):564–570.[27] O’Connell K, Clark A, Hopman W, Lakoff J. Thyroid Nodule Growth as A Predictor
  74. of Malignancy. Endocrine Practice. 2019;25(10):1029–1034.
  75. [28] Gallardo GL, Sastre J, Gonzalez A, Arranz S, Silva J, Valero MA et al. Thyroid nodule
  76. size at ultrasound as a predictor of malignancy. Endocrine Abstracts. 2017;p. 49.
  77. [29] Megwalu UC. Risk of Malignancy in Thyroid Nodules 4 cm or Larger. Endocrinology
  78. and Metabolism. 2017;32(1):77.
  79. [30] Al-Hakami HA, Alqahtani R, Alahmadi A, Almutairi D, Algarni M, Alandejani T.
  80. Thyroid Nodule Size and Prediction of Cancer: A Study at Tertiary Care Hospital in
  81. Saudi Arabia. Cureus. 2020;12(3).
  82. [31] Al-Hakami HA, Alqahtani R, Alahmadi A, Almutairi D, Algarni M, Alandejani T.
  83. Thyroid Nodule Size and Prediction of Cancer: A Study at Tertiary Care Hospital in
  84. Saudi Arabia. Cureus. 2020;12(3).